Results 141 to 150 of about 1,700 (160)
Some of the next articles are maybe not open access.
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2019
Scleromyxedema is a rare disorder that frequently affects multiple extracutaneous organ systems and is usually associated with monoclonal gammopathy. The pathogenesis of scleromyxedema is unknown. The clinical course is chronic and progressive and can lead to marked morbidity or death.
M, Neufeld +2 more
openaire +1 more source
Scleromyxedema is a rare disorder that frequently affects multiple extracutaneous organ systems and is usually associated with monoclonal gammopathy. The pathogenesis of scleromyxedema is unknown. The clinical course is chronic and progressive and can lead to marked morbidity or death.
M, Neufeld +2 more
openaire +1 more source
Dermatologie (Heidelberg, Germany)
Scleromyxedema or generalized diffuse lichen myxoedematosus is a rare mucinosis that is associated with monoclonal gammopathy and which frequently affects multiple extracutaneous organ systems. The pathogenesis of scleromyxedema has not been fully elucidated, but includes stimulation of glycosaminoglycan synthesis. The clinical course of scleromyxedema
Cord, Sunderkötter +2 more
openaire +1 more source
Scleromyxedema or generalized diffuse lichen myxoedematosus is a rare mucinosis that is associated with monoclonal gammopathy and which frequently affects multiple extracutaneous organ systems. The pathogenesis of scleromyxedema has not been fully elucidated, but includes stimulation of glycosaminoglycan synthesis. The clinical course of scleromyxedema
Cord, Sunderkötter +2 more
openaire +1 more source
Zeitschrift fur Hautkrankheiten, 1986
In a 51-year-old man scleromyxedema developed gradually from mucinosis papulosa over 13 years. Paraproteins of the type IgG-lambda were discovered in this patient.
E, Varga, A, Kiss, I, Schneider
openaire +1 more source
In a 51-year-old man scleromyxedema developed gradually from mucinosis papulosa over 13 years. Paraproteins of the type IgG-lambda were discovered in this patient.
E, Varga, A, Kiss, I, Schneider
openaire +1 more source
40528 Administration of bortezomib in patients with refractory scleromyxedema: A case report
Journal of American Academy of Dermatology, 2023Austin Mueller, Michael Kwa, H. Kerr
semanticscholar +1 more source
Unveiling the enigma: a case-based review of scleromyxedema
Rheumatology InternationalJagoda Rogowska +3 more
semanticscholar +1 more source